We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
CALL
Energy Transfer Partners
ET
$70B
| $1.11M | ﹤0.01% |
+105,600
| New | +$1.01M |
|
|
CFXA
3202
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $1.11M | ﹤0.01% |
6,000
| – | – |
|
3203
CALL
Xerox
XRX
$412M
| $1.11M | ﹤0.01% |
47,700
| – | – |
|
|
LDL
3204
DELISTED
Lydall, Inc.
LDL
| $1.11M | ﹤0.01% |
+18,151
| New | +$698K |
|
|
INFN
3205
DELISTED
Infinera Corporation Common Stock
INFN
| $1.1M | ﹤0.01% |
108,316
-31,560
| -23% | -$306K |
|
|
KL
3206
PUT
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $1.1M | ﹤0.01% |
29,000
+14,500
| +100% | +$581K |
|
3207
MarineMax
HZO
$796M
| $1.1M | ﹤0.01% |
22,808
-8,969
| -28% | -$468K |
|
3208
First Trust North American Energy Infrastructure Fund
EMLP
$4.08B
| $1.1M | ﹤0.01% |
+45,000
| New | +$1.09M |
|
3209
Genesco
GCO
$436M
| $1.1M | ﹤0.01% |
17,629
-4,540
| -20% | -$246K |
|
3210
CALL
Pultegroup
PHM
$25.3B
| $1.1M | ﹤0.01% |
+19,800
| New | +$1.11M |
|
|
VSTA
3211
DELISTED
Vasta Platform
VSTA
| $1.1M | ﹤0.01% |
135,372
-589,628
| -81% | -$5.23M |
|
3212
Par Pacific Holdings
PARR
$3.51B
| $1.1M | ﹤0.01% |
68,635
-1,213
| -2% | -$18.2K |
|
|
LAC
3213
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $1.1M | ﹤0.01% |
73,975
-7,052
| -9% | -$101K |
|
|
SRDX
3214
DELISTED
Surmodics
SRDX
| $1.1M | ﹤0.01% |
20,206
+4,635
| +30% | +$254K |
|
3215
Extreme Networks
EXTR
$3.43B
| $1.09M | ﹤0.01% |
97,752
-20,931
| -18% | -$222K |
|
3216
MannKind Corp
MNKD
$1.31B
| $1.09M | ﹤0.01% |
200,356
+173,629
| +650% | +$752K |
|
3217
PJT Partners
PJT
$4.45B
| $1.09M | ﹤0.01% |
15,307
-124
| -0.8% | -$8.85K |
|
3218
MakeMyTrip
MMYT
$5.76B
| $1.09M | ﹤0.01% |
36,226
+16,528
| +84% | +$459K |
|
3219
Rocket Pharmaceuticals
RCKT
$382M
| $1.09M | ﹤0.01% |
24,553
+30
| +0.1% | +$1.3K |
|
3220
Bally's
BALY
$686M
| $1.08M | ﹤0.01% |
20,332
+10,223
| +101% | +$576K |
|
3221
CALL
Clean Energy Fuels
CLNE
$414M
| $1.08M | ﹤0.01% |
106,900
+56,900
| +114% | +$587K |
|
3222
Energy Recovery
ERII
$457M
| $1.08M | ﹤0.01% |
47,552
+6,520
| +16% | +$129K |
|
3223
Laureate Education
LAUR
$5.24B
| $1.08M | ﹤0.01% |
74,600
-4,443
| -6% | -$62.8K |
|
|
TARO
3224
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.08M | ﹤0.01% |
14,983
-3,941
| -21% | -$289K |
|
3225
Sphere Entertainment
SPHR
$5.77B
| $1.08M | ﹤0.01% |
13,248
-9,761
| -42% | -$864K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.